Li Kang Biomedical Co Ltd (6242) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.077x

Based on the latest financial reports, Li Kang Biomedical Co Ltd (6242) has a cash flow conversion efficiency ratio of 0.077x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$67.23 Million ≈ $2.12 Million USD) by net assets (NT$871.24 Million ≈ $27.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 6242 net asset quality index to measure how much of total assets are equity-financed.

Li Kang Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Li Kang Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 6242 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Li Kang Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Li Kang Biomedical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HS Valve Co. Ltd KQ:039610	0.001x
Unite Group PLC LSE:UTG	0.019x
Legacy Iron Ore Ltd AU:LCY	0.095x
PTL LTD Ordinary Shares NASDAQ:PTLE	-0.445x
Corem Property Group AB (publ) ST:CORE-A	0.001x
CORESTEM Inc KQ:166480	-0.103x
Coventry Group Ltd AU:CYG	0.024x
Total Soft Bank Ltd KQ:045340	0.094x

Annual Cash Flow Conversion Efficiency for Li Kang Biomedical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Li Kang Biomedical Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Li Kang Biomedical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$871.24 Million ≈ $27.45 Million	NT$92.15 Million ≈ $2.90 Million	0.106x	+38.42%
2024-12-31	NT$855.68 Million ≈ $26.96 Million	NT$65.38 Million ≈ $2.06 Million	0.076x	-50.24%
2023-12-31	NT$630.03 Million ≈ $19.85 Million	NT$96.74 Million ≈ $3.05 Million	0.154x	-44.32%
2022-12-31	NT$570.14 Million ≈ $17.96 Million	NT$157.24 Million ≈ $4.95 Million	0.276x	+124.49%
2021-12-31	NT$492.00 Million ≈ $15.50 Million	NT$60.45 Million ≈ $1.90 Million	0.123x	-23.53%
2020-12-31	NT$508.30 Million ≈ $16.01 Million	NT$81.67 Million ≈ $2.57 Million	0.161x	-16.08%
2019-12-31	NT$483.44 Million ≈ $15.23 Million	NT$92.56 Million ≈ $2.92 Million	0.191x	-15.29%
2018-12-31	NT$466.92 Million ≈ $14.71 Million	NT$105.53 Million ≈ $3.32 Million	0.226x	-8.94%
2017-12-31	NT$445.68 Million ≈ $14.04 Million	NT$110.61 Million ≈ $3.48 Million	0.248x	-23.67%
2016-12-31	NT$340.80 Million ≈ $10.74 Million	NT$110.82 Million ≈ $3.49 Million	0.325x	+42.61%
2015-12-31	NT$280.29 Million ≈ $8.83 Million	NT$63.91 Million ≈ $2.01 Million	0.228x	+24.49%
2014-12-31	NT$227.44 Million ≈ $7.17 Million	NT$41.66 Million ≈ $1.31 Million	0.183x	-18.77%
2009-12-31	NT$128.49 Million ≈ $4.05 Million	NT$28.97 Million ≈ $912.65K	0.225x	+1252.82%
2003-12-31	NT$338.06 Million ≈ $10.65 Million	NT$5.63 Million ≈ $177.50K	0.017x	-87.37%
2002-12-31	NT$347.64 Million ≈ $10.95 Million	NT$45.87 Million ≈ $1.45 Million	0.132x	--

About Li Kang Biomedical Co Ltd

TWO:6242 Taiwan Travel Services

Market Cap

$34.47 Million

NT$1.09 Billion TWD

Market Cap Rank

#23212 Global

#1450 in Taiwan

Share Price

NT$34.40

Change (1 day)

-0.72%

52-Week Range

NT$34.40 - NT$42.95

All Time High

NT$13364.93